ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Infectious Disease Diagnostics Testing Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Othe-2O272
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Infectious Disease Diagnostics Testing Market Size Status and Forecast 2021 2027
BUY CHAPTERS

Global Infectious Disease Diagnostics Testing Market Research Report 2025

Code: QYRE-Othe-2O272
Report
September 2025
Pages:92
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
bioMérieux
Roche Diagnostic
Beckman Coulter
Becton Dickinson and Company
Bio Rad Laboratories
Cavidi
Corgenix
Diaxonhit
Eiken Chemical
EMD Millipore
Epitope Diagnostic
EUROIMMUN
Gold Standard Diagnostics
Hologic Inc
Immunetics
InBios International
Abbott
Cepheid Inc
DiaSorin

Infectious Disease Diagnostics Testing Market Size

The global market for Infectious Disease Diagnostics Testing was valued at US$ 17700 million in the year 2024 and is projected to reach a revised size of US$ 22440 million by 2031, growing at a CAGR of 3.5% during the forecast period.

Infectious Disease Diagnostics Testing Market

Infectious Disease Diagnostics Testing Market

In hospitals, infectious disease specialists help ensure the timely diagnosis and treatment of acute infections by recommending the appropriate diagnostic tests to identify the source of the infection and by recommending the appropriate antibiotic to treat the infection.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Infectious Disease Diagnostics Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Infectious Disease Diagnostics Testing.
The Infectious Disease Diagnostics Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Infectious Disease Diagnostics Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Infectious Disease Diagnostics Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Infectious Disease Diagnostics Testing Market Report

Report Metric Details
Report Name Infectious Disease Diagnostics Testing Market
Accounted market size in year US$ 17700 million
Forecasted market size in 2031 US$ 22440 million
CAGR 3.5%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Molecular Diagnostic Test
  • POC Infectious Disease Diagnostics Test
Segment by Application
  • Hospital
  • Academics Research
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Abbott, bioMérieux, Diasorin, Roche Diagnostic, Beckman Coulter, Becton, Dickinson and Company, Bio-Rad Laboratories, Cavidi, Cepheid, Corgenix, Diaxonhit, Eiken Chemical, EMD Millipore, Epitope Diagnostic, EUROIMMUN, Gold Standard Diagnostics, Hologic, Immunetics, InBios International
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Infectious Disease Diagnostics Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Infectious Disease Diagnostics Testing Market growing?

Ans: The Infectious Disease Diagnostics Testing Market witnessing a CAGR of 3.5% during the forecast period 2025-2031.

What is the Infectious Disease Diagnostics Testing Market size in 2031?

Ans: The Infectious Disease Diagnostics Testing Market size in 2031 will be US$ 22440 million.

Who are the main players in the Infectious Disease Diagnostics Testing Market report?

Ans: The main players in the Infectious Disease Diagnostics Testing Market are Abbott, bioMérieux, Diasorin, Roche Diagnostic, Beckman Coulter, Becton, Dickinson and Company, Bio-Rad Laboratories, Cavidi, Cepheid, Corgenix, Diaxonhit, Eiken Chemical, EMD Millipore, Epitope Diagnostic, EUROIMMUN, Gold Standard Diagnostics, Hologic, Immunetics, InBios International

What are the Application segmentation covered in the Infectious Disease Diagnostics Testing Market report?

Ans: The Applications covered in the Infectious Disease Diagnostics Testing Market report are Hospital, Academics Research, Others

What are the Type segmentation covered in the Infectious Disease Diagnostics Testing Market report?

Ans: The Types covered in the Infectious Disease Diagnostics Testing Market report are Molecular Diagnostic Test, POC Infectious Disease Diagnostics Test

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Infectious Disease Diagnostics Testing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Molecular Diagnostic Test
1.2.3 POC Infectious Disease Diagnostics Test
1.3 Market by Application
1.3.1 Global Infectious Disease Diagnostics Testing Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Academics Research
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Infectious Disease Diagnostics Testing Market Perspective (2020-2031)
2.2 Global Infectious Disease Diagnostics Testing Growth Trends by Region
2.2.1 Global Infectious Disease Diagnostics Testing Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Infectious Disease Diagnostics Testing Historic Market Size by Region (2020-2025)
2.2.3 Infectious Disease Diagnostics Testing Forecasted Market Size by Region (2026-2031)
2.3 Infectious Disease Diagnostics Testing Market Dynamics
2.3.1 Infectious Disease Diagnostics Testing Industry Trends
2.3.2 Infectious Disease Diagnostics Testing Market Drivers
2.3.3 Infectious Disease Diagnostics Testing Market Challenges
2.3.4 Infectious Disease Diagnostics Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Infectious Disease Diagnostics Testing Players by Revenue
3.1.1 Global Top Infectious Disease Diagnostics Testing Players by Revenue (2020-2025)
3.1.2 Global Infectious Disease Diagnostics Testing Revenue Market Share by Players (2020-2025)
3.2 Global Infectious Disease Diagnostics Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Infectious Disease Diagnostics Testing Revenue
3.4 Global Infectious Disease Diagnostics Testing Market Concentration Ratio
3.4.1 Global Infectious Disease Diagnostics Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Infectious Disease Diagnostics Testing Revenue in 2024
3.5 Global Key Players of Infectious Disease Diagnostics Testing Head office and Area Served
3.6 Global Key Players of Infectious Disease Diagnostics Testing, Product and Application
3.7 Global Key Players of Infectious Disease Diagnostics Testing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Infectious Disease Diagnostics Testing Breakdown Data by Type
4.1 Global Infectious Disease Diagnostics Testing Historic Market Size by Type (2020-2025)
4.2 Global Infectious Disease Diagnostics Testing Forecasted Market Size by Type (2026-2031)
5 Infectious Disease Diagnostics Testing Breakdown Data by Application
5.1 Global Infectious Disease Diagnostics Testing Historic Market Size by Application (2020-2025)
5.2 Global Infectious Disease Diagnostics Testing Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Infectious Disease Diagnostics Testing Market Size (2020-2031)
6.2 North America Infectious Disease Diagnostics Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Infectious Disease Diagnostics Testing Market Size by Country (2020-2025)
6.4 North America Infectious Disease Diagnostics Testing Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Infectious Disease Diagnostics Testing Market Size (2020-2031)
7.2 Europe Infectious Disease Diagnostics Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Infectious Disease Diagnostics Testing Market Size by Country (2020-2025)
7.4 Europe Infectious Disease Diagnostics Testing Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Infectious Disease Diagnostics Testing Market Size (2020-2031)
8.2 Asia-Pacific Infectious Disease Diagnostics Testing Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Infectious Disease Diagnostics Testing Market Size by Region (2020-2025)
8.4 Asia-Pacific Infectious Disease Diagnostics Testing Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Infectious Disease Diagnostics Testing Market Size (2020-2031)
9.2 Latin America Infectious Disease Diagnostics Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Infectious Disease Diagnostics Testing Market Size by Country (2020-2025)
9.4 Latin America Infectious Disease Diagnostics Testing Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Infectious Disease Diagnostics Testing Market Size (2020-2031)
10.2 Middle East & Africa Infectious Disease Diagnostics Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Infectious Disease Diagnostics Testing Market Size by Country (2020-2025)
10.4 Middle East & Africa Infectious Disease Diagnostics Testing Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Infectious Disease Diagnostics Testing Introduction
11.1.4 Abbott Revenue in Infectious Disease Diagnostics Testing Business (2020-2025)
11.1.5 Abbott Recent Development
11.2 bioMérieux
11.2.1 bioMérieux Company Details
11.2.2 bioMérieux Business Overview
11.2.3 bioMérieux Infectious Disease Diagnostics Testing Introduction
11.2.4 bioMérieux Revenue in Infectious Disease Diagnostics Testing Business (2020-2025)
11.2.5 bioMérieux Recent Development
11.3 Diasorin
11.3.1 Diasorin Company Details
11.3.2 Diasorin Business Overview
11.3.3 Diasorin Infectious Disease Diagnostics Testing Introduction
11.3.4 Diasorin Revenue in Infectious Disease Diagnostics Testing Business (2020-2025)
11.3.5 Diasorin Recent Development
11.4 Roche Diagnostic
11.4.1 Roche Diagnostic Company Details
11.4.2 Roche Diagnostic Business Overview
11.4.3 Roche Diagnostic Infectious Disease Diagnostics Testing Introduction
11.4.4 Roche Diagnostic Revenue in Infectious Disease Diagnostics Testing Business (2020-2025)
11.4.5 Roche Diagnostic Recent Development
11.5 Beckman Coulter
11.5.1 Beckman Coulter Company Details
11.5.2 Beckman Coulter Business Overview
11.5.3 Beckman Coulter Infectious Disease Diagnostics Testing Introduction
11.5.4 Beckman Coulter Revenue in Infectious Disease Diagnostics Testing Business (2020-2025)
11.5.5 Beckman Coulter Recent Development
11.6 Becton, Dickinson and Company
11.6.1 Becton, Dickinson and Company Company Details
11.6.2 Becton, Dickinson and Company Business Overview
11.6.3 Becton, Dickinson and Company Infectious Disease Diagnostics Testing Introduction
11.6.4 Becton, Dickinson and Company Revenue in Infectious Disease Diagnostics Testing Business (2020-2025)
11.6.5 Becton, Dickinson and Company Recent Development
11.7 Bio-Rad Laboratories
11.7.1 Bio-Rad Laboratories Company Details
11.7.2 Bio-Rad Laboratories Business Overview
11.7.3 Bio-Rad Laboratories Infectious Disease Diagnostics Testing Introduction
11.7.4 Bio-Rad Laboratories Revenue in Infectious Disease Diagnostics Testing Business (2020-2025)
11.7.5 Bio-Rad Laboratories Recent Development
11.8 Cavidi
11.8.1 Cavidi Company Details
11.8.2 Cavidi Business Overview
11.8.3 Cavidi Infectious Disease Diagnostics Testing Introduction
11.8.4 Cavidi Revenue in Infectious Disease Diagnostics Testing Business (2020-2025)
11.8.5 Cavidi Recent Development
11.9 Cepheid
11.9.1 Cepheid Company Details
11.9.2 Cepheid Business Overview
11.9.3 Cepheid Infectious Disease Diagnostics Testing Introduction
11.9.4 Cepheid Revenue in Infectious Disease Diagnostics Testing Business (2020-2025)
11.9.5 Cepheid Recent Development
11.10 Corgenix
11.10.1 Corgenix Company Details
11.10.2 Corgenix Business Overview
11.10.3 Corgenix Infectious Disease Diagnostics Testing Introduction
11.10.4 Corgenix Revenue in Infectious Disease Diagnostics Testing Business (2020-2025)
11.10.5 Corgenix Recent Development
11.11 Diaxonhit
11.11.1 Diaxonhit Company Details
11.11.2 Diaxonhit Business Overview
11.11.3 Diaxonhit Infectious Disease Diagnostics Testing Introduction
11.11.4 Diaxonhit Revenue in Infectious Disease Diagnostics Testing Business (2020-2025)
11.11.5 Diaxonhit Recent Development
11.12 Eiken Chemical
11.12.1 Eiken Chemical Company Details
11.12.2 Eiken Chemical Business Overview
11.12.3 Eiken Chemical Infectious Disease Diagnostics Testing Introduction
11.12.4 Eiken Chemical Revenue in Infectious Disease Diagnostics Testing Business (2020-2025)
11.12.5 Eiken Chemical Recent Development
11.13 EMD Millipore
11.13.1 EMD Millipore Company Details
11.13.2 EMD Millipore Business Overview
11.13.3 EMD Millipore Infectious Disease Diagnostics Testing Introduction
11.13.4 EMD Millipore Revenue in Infectious Disease Diagnostics Testing Business (2020-2025)
11.13.5 EMD Millipore Recent Development
11.14 Epitope Diagnostic
11.14.1 Epitope Diagnostic Company Details
11.14.2 Epitope Diagnostic Business Overview
11.14.3 Epitope Diagnostic Infectious Disease Diagnostics Testing Introduction
11.14.4 Epitope Diagnostic Revenue in Infectious Disease Diagnostics Testing Business (2020-2025)
11.14.5 Epitope Diagnostic Recent Development
11.15 EUROIMMUN
11.15.1 EUROIMMUN Company Details
11.15.2 EUROIMMUN Business Overview
11.15.3 EUROIMMUN Infectious Disease Diagnostics Testing Introduction
11.15.4 EUROIMMUN Revenue in Infectious Disease Diagnostics Testing Business (2020-2025)
11.15.5 EUROIMMUN Recent Development
11.16 Gold Standard Diagnostics
11.16.1 Gold Standard Diagnostics Company Details
11.16.2 Gold Standard Diagnostics Business Overview
11.16.3 Gold Standard Diagnostics Infectious Disease Diagnostics Testing Introduction
11.16.4 Gold Standard Diagnostics Revenue in Infectious Disease Diagnostics Testing Business (2020-2025)
11.16.5 Gold Standard Diagnostics Recent Development
11.17 Hologic
11.17.1 Hologic Company Details
11.17.2 Hologic Business Overview
11.17.3 Hologic Infectious Disease Diagnostics Testing Introduction
11.17.4 Hologic Revenue in Infectious Disease Diagnostics Testing Business (2020-2025)
11.17.5 Hologic Recent Development
11.18 Immunetics
11.18.1 Immunetics Company Details
11.18.2 Immunetics Business Overview
11.18.3 Immunetics Infectious Disease Diagnostics Testing Introduction
11.18.4 Immunetics Revenue in Infectious Disease Diagnostics Testing Business (2020-2025)
11.18.5 Immunetics Recent Development
11.19 InBios International
11.19.1 InBios International Company Details
11.19.2 InBios International Business Overview
11.19.3 InBios International Infectious Disease Diagnostics Testing Introduction
11.19.4 InBios International Revenue in Infectious Disease Diagnostics Testing Business (2020-2025)
11.19.5 InBios International Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
bioMérieux
Roche Diagnostic
Beckman Coulter
Becton Dickinson and Company
Bio Rad Laboratories
Cavidi
Corgenix
Diaxonhit
Eiken Chemical
EMD Millipore
Epitope Diagnostic
EUROIMMUN
Gold Standard Diagnostics
Hologic Inc
Immunetics
InBios International
Abbott
Cepheid Inc
DiaSorin
List of Tables
 Table 1. Global Infectious Disease Diagnostics Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Molecular Diagnostic Test
 Table 3. Key Players of POC Infectious Disease Diagnostics Test
 Table 4. Global Infectious Disease Diagnostics Testing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Infectious Disease Diagnostics Testing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Infectious Disease Diagnostics Testing Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Infectious Disease Diagnostics Testing Market Share by Region (2020-2025)
 Table 8. Global Infectious Disease Diagnostics Testing Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Infectious Disease Diagnostics Testing Market Share by Region (2026-2031)
 Table 10. Infectious Disease Diagnostics Testing Market Trends
 Table 11. Infectious Disease Diagnostics Testing Market Drivers
 Table 12. Infectious Disease Diagnostics Testing Market Challenges
 Table 13. Infectious Disease Diagnostics Testing Market Restraints
 Table 14. Global Infectious Disease Diagnostics Testing Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Infectious Disease Diagnostics Testing Market Share by Players (2020-2025)
 Table 16. Global Top Infectious Disease Diagnostics Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Disease Diagnostics Testing as of 2024)
 Table 17. Ranking of Global Top Infectious Disease Diagnostics Testing Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Infectious Disease Diagnostics Testing Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Infectious Disease Diagnostics Testing, Headquarters and Area Served
 Table 20. Global Key Players of Infectious Disease Diagnostics Testing, Product and Application
 Table 21. Global Key Players of Infectious Disease Diagnostics Testing, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Infectious Disease Diagnostics Testing Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Infectious Disease Diagnostics Testing Revenue Market Share by Type (2020-2025)
 Table 25. Global Infectious Disease Diagnostics Testing Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Infectious Disease Diagnostics Testing Revenue Market Share by Type (2026-2031)
 Table 27. Global Infectious Disease Diagnostics Testing Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Infectious Disease Diagnostics Testing Revenue Market Share by Application (2020-2025)
 Table 29. Global Infectious Disease Diagnostics Testing Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Infectious Disease Diagnostics Testing Revenue Market Share by Application (2026-2031)
 Table 31. North America Infectious Disease Diagnostics Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Infectious Disease Diagnostics Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Infectious Disease Diagnostics Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Infectious Disease Diagnostics Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Infectious Disease Diagnostics Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Infectious Disease Diagnostics Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Infectious Disease Diagnostics Testing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Infectious Disease Diagnostics Testing Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Infectious Disease Diagnostics Testing Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Infectious Disease Diagnostics Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Infectious Disease Diagnostics Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Infectious Disease Diagnostics Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Infectious Disease Diagnostics Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Infectious Disease Diagnostics Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Infectious Disease Diagnostics Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Abbott Company Details
 Table 47. Abbott Business Overview
 Table 48. Abbott Infectious Disease Diagnostics Testing Product
 Table 49. Abbott Revenue in Infectious Disease Diagnostics Testing Business (2020-2025) & (US$ Million)
 Table 50. Abbott Recent Development
 Table 51. bioMérieux Company Details
 Table 52. bioMérieux Business Overview
 Table 53. bioMérieux Infectious Disease Diagnostics Testing Product
 Table 54. bioMérieux Revenue in Infectious Disease Diagnostics Testing Business (2020-2025) & (US$ Million)
 Table 55. bioMérieux Recent Development
 Table 56. Diasorin Company Details
 Table 57. Diasorin Business Overview
 Table 58. Diasorin Infectious Disease Diagnostics Testing Product
 Table 59. Diasorin Revenue in Infectious Disease Diagnostics Testing Business (2020-2025) & (US$ Million)
 Table 60. Diasorin Recent Development
 Table 61. Roche Diagnostic Company Details
 Table 62. Roche Diagnostic Business Overview
 Table 63. Roche Diagnostic Infectious Disease Diagnostics Testing Product
 Table 64. Roche Diagnostic Revenue in Infectious Disease Diagnostics Testing Business (2020-2025) & (US$ Million)
 Table 65. Roche Diagnostic Recent Development
 Table 66. Beckman Coulter Company Details
 Table 67. Beckman Coulter Business Overview
 Table 68. Beckman Coulter Infectious Disease Diagnostics Testing Product
 Table 69. Beckman Coulter Revenue in Infectious Disease Diagnostics Testing Business (2020-2025) & (US$ Million)
 Table 70. Beckman Coulter Recent Development
 Table 71. Becton, Dickinson and Company Company Details
 Table 72. Becton, Dickinson and Company Business Overview
 Table 73. Becton, Dickinson and Company Infectious Disease Diagnostics Testing Product
 Table 74. Becton, Dickinson and Company Revenue in Infectious Disease Diagnostics Testing Business (2020-2025) & (US$ Million)
 Table 75. Becton, Dickinson and Company Recent Development
 Table 76. Bio-Rad Laboratories Company Details
 Table 77. Bio-Rad Laboratories Business Overview
 Table 78. Bio-Rad Laboratories Infectious Disease Diagnostics Testing Product
 Table 79. Bio-Rad Laboratories Revenue in Infectious Disease Diagnostics Testing Business (2020-2025) & (US$ Million)
 Table 80. Bio-Rad Laboratories Recent Development
 Table 81. Cavidi Company Details
 Table 82. Cavidi Business Overview
 Table 83. Cavidi Infectious Disease Diagnostics Testing Product
 Table 84. Cavidi Revenue in Infectious Disease Diagnostics Testing Business (2020-2025) & (US$ Million)
 Table 85. Cavidi Recent Development
 Table 86. Cepheid Company Details
 Table 87. Cepheid Business Overview
 Table 88. Cepheid Infectious Disease Diagnostics Testing Product
 Table 89. Cepheid Revenue in Infectious Disease Diagnostics Testing Business (2020-2025) & (US$ Million)
 Table 90. Cepheid Recent Development
 Table 91. Corgenix Company Details
 Table 92. Corgenix Business Overview
 Table 93. Corgenix Infectious Disease Diagnostics Testing Product
 Table 94. Corgenix Revenue in Infectious Disease Diagnostics Testing Business (2020-2025) & (US$ Million)
 Table 95. Corgenix Recent Development
 Table 96. Diaxonhit Company Details
 Table 97. Diaxonhit Business Overview
 Table 98. Diaxonhit Infectious Disease Diagnostics Testing Product
 Table 99. Diaxonhit Revenue in Infectious Disease Diagnostics Testing Business (2020-2025) & (US$ Million)
 Table 100. Diaxonhit Recent Development
 Table 101. Eiken Chemical Company Details
 Table 102. Eiken Chemical Business Overview
 Table 103. Eiken Chemical Infectious Disease Diagnostics Testing Product
 Table 104. Eiken Chemical Revenue in Infectious Disease Diagnostics Testing Business (2020-2025) & (US$ Million)
 Table 105. Eiken Chemical Recent Development
 Table 106. EMD Millipore Company Details
 Table 107. EMD Millipore Business Overview
 Table 108. EMD Millipore Infectious Disease Diagnostics Testing Product
 Table 109. EMD Millipore Revenue in Infectious Disease Diagnostics Testing Business (2020-2025) & (US$ Million)
 Table 110. EMD Millipore Recent Development
 Table 111. Epitope Diagnostic Company Details
 Table 112. Epitope Diagnostic Business Overview
 Table 113. Epitope Diagnostic Infectious Disease Diagnostics Testing Product
 Table 114. Epitope Diagnostic Revenue in Infectious Disease Diagnostics Testing Business (2020-2025) & (US$ Million)
 Table 115. Epitope Diagnostic Recent Development
 Table 116. EUROIMMUN Company Details
 Table 117. EUROIMMUN Business Overview
 Table 118. EUROIMMUN Infectious Disease Diagnostics Testing Product
 Table 119. EUROIMMUN Revenue in Infectious Disease Diagnostics Testing Business (2020-2025) & (US$ Million)
 Table 120. EUROIMMUN Recent Development
 Table 121. Gold Standard Diagnostics Company Details
 Table 122. Gold Standard Diagnostics Business Overview
 Table 123. Gold Standard Diagnostics Infectious Disease Diagnostics Testing Product
 Table 124. Gold Standard Diagnostics Revenue in Infectious Disease Diagnostics Testing Business (2020-2025) & (US$ Million)
 Table 125. Gold Standard Diagnostics Recent Development
 Table 126. Hologic Company Details
 Table 127. Hologic Business Overview
 Table 128. Hologic Infectious Disease Diagnostics Testing Product
 Table 129. Hologic Revenue in Infectious Disease Diagnostics Testing Business (2020-2025) & (US$ Million)
 Table 130. Hologic Recent Development
 Table 131. Immunetics Company Details
 Table 132. Immunetics Business Overview
 Table 133. Immunetics Infectious Disease Diagnostics Testing Product
 Table 134. Immunetics Revenue in Infectious Disease Diagnostics Testing Business (2020-2025) & (US$ Million)
 Table 135. Immunetics Recent Development
 Table 136. InBios International Company Details
 Table 137. InBios International Business Overview
 Table 138. InBios International Infectious Disease Diagnostics Testing Product
 Table 139. InBios International Revenue in Infectious Disease Diagnostics Testing Business (2020-2025) & (US$ Million)
 Table 140. InBios International Recent Development
 Table 141. Research Programs/Design for This Report
 Table 142. Key Data Information from Secondary Sources
 Table 143. Key Data Information from Primary Sources
 Table 144. Authors List of This Report


List of Figures
 Figure 1. Infectious Disease Diagnostics Testing Picture
 Figure 2. Global Infectious Disease Diagnostics Testing Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Infectious Disease Diagnostics Testing Market Share by Type: 2024 VS 2031
 Figure 4. Molecular Diagnostic Test Features
 Figure 5. POC Infectious Disease Diagnostics Test Features
 Figure 6. Global Infectious Disease Diagnostics Testing Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Infectious Disease Diagnostics Testing Market Share by Application: 2024 VS 2031
 Figure 8. Hospital Case Studies
 Figure 9. Academics Research Case Studies
 Figure 10. Others Case Studies
 Figure 11. Infectious Disease Diagnostics Testing Report Years Considered
 Figure 12. Global Infectious Disease Diagnostics Testing Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 13. Global Infectious Disease Diagnostics Testing Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Infectious Disease Diagnostics Testing Market Share by Region: 2024 VS 2031
 Figure 15. Global Infectious Disease Diagnostics Testing Market Share by Players in 2024
 Figure 16. Global Top Infectious Disease Diagnostics Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Disease Diagnostics Testing as of 2024)
 Figure 17. The Top 10 and 5 Players Market Share by Infectious Disease Diagnostics Testing Revenue in 2024
 Figure 18. North America Infectious Disease Diagnostics Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 19. North America Infectious Disease Diagnostics Testing Market Share by Country (2020-2031)
 Figure 20. United States Infectious Disease Diagnostics Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Canada Infectious Disease Diagnostics Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe Infectious Disease Diagnostics Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Infectious Disease Diagnostics Testing Market Share by Country (2020-2031)
 Figure 24. Germany Infectious Disease Diagnostics Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. France Infectious Disease Diagnostics Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. U.K. Infectious Disease Diagnostics Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Italy Infectious Disease Diagnostics Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Russia Infectious Disease Diagnostics Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Nordic Countries Infectious Disease Diagnostics Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific Infectious Disease Diagnostics Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Infectious Disease Diagnostics Testing Market Share by Region (2020-2031)
 Figure 32. China Infectious Disease Diagnostics Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Japan Infectious Disease Diagnostics Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. South Korea Infectious Disease Diagnostics Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Southeast Asia Infectious Disease Diagnostics Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. India Infectious Disease Diagnostics Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Australia Infectious Disease Diagnostics Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America Infectious Disease Diagnostics Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Infectious Disease Diagnostics Testing Market Share by Country (2020-2031)
 Figure 40. Mexico Infectious Disease Diagnostics Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Brazil Infectious Disease Diagnostics Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa Infectious Disease Diagnostics Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Infectious Disease Diagnostics Testing Market Share by Country (2020-2031)
 Figure 44. Turkey Infectious Disease Diagnostics Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Saudi Arabia Infectious Disease Diagnostics Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. UAE Infectious Disease Diagnostics Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Abbott Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2020-2025)
 Figure 48. bioMérieux Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2020-2025)
 Figure 49. Diasorin Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2020-2025)
 Figure 50. Roche Diagnostic Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2020-2025)
 Figure 51. Beckman Coulter Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2020-2025)
 Figure 52. Becton, Dickinson and Company Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2020-2025)
 Figure 53. Bio-Rad Laboratories Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2020-2025)
 Figure 54. Cavidi Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2020-2025)
 Figure 55. Cepheid Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2020-2025)
 Figure 56. Corgenix Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2020-2025)
 Figure 57. Diaxonhit Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2020-2025)
 Figure 58. Eiken Chemical Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2020-2025)
 Figure 59. EMD Millipore Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2020-2025)
 Figure 60. Epitope Diagnostic Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2020-2025)
 Figure 61. EUROIMMUN Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2020-2025)
 Figure 62. Gold Standard Diagnostics Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2020-2025)
 Figure 63. Hologic Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2020-2025)
 Figure 64. Immunetics Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2020-2025)
 Figure 65. InBios International Revenue Growth Rate in Infectious Disease Diagnostics Testing Business (2020-2025)
 Figure 66. Bottom-up and Top-down Approaches for This Report
 Figure 67. Data Triangulation
 Figure 68. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

Infectious Disease Testing Market
Infectious Disease Testing Kits Market
Infectious Disease Diagnostic
Infection Surveillance Solution Market
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions